Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.39
Delayed Data
As of Sep 04
 +0.05 / +3.73%
Today’s Change
0.61
Today|||52-Week Range
3.50
+65.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line30.6M-114.4M-107.0M-52.7M
 
 
 
 
 
Depreciation1.7M2.5M3.8M6.2M
 
 
 
 
 
Total Other Cash Flow10.4M10.9M5.4M10.8M
 
 
 
 
 
Funds From Operations42.7M-101.0M-97.8M-35.7M
 
 
 
 
 
Funds From/For Other Operating Expenses16.2M4.7M-13.4M19.2M
 
 
 
 
 
Net Cash Flow - Operating Activities26.5M-105.7M-84.4M-54.8M
 
 
 
 
 
 
InvestingIncrease In Investments-376.3M-194.6M-175.4M-42.3M
 
 
 
 
 
Decrease In Investments234.8M339.8M191.1M109.8M
 
 
 
 
 
Capital Expenditures-2.6M-9.9M-3.7M-12.9M
 
 
 
 
 
Fixed Asset Disposal0.00----191.0K
 
 
Net Cash Flow Investing-144.1M135.2M12.1M54.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.003.7M0.008.6M
 
 
 
Long Term Debt Reduction0.00-2.2M-7.1M-7.8M
 
 
 
 
Net Proceeds Stock Sale115.4M1.6M53.6M191.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00465.0K0.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing115.4M3.1M47.0M1.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash---26.0K26.0K0.00
 
 
 
 
Net Change In Cash-2.3M32.7M-25.3M882.0K